The U.S. Food and Drug Administration (FDA) has granted fast track designation to VT3989, a novel investigational small molecule cancer therapeutic, for the treatment of patients with unresectable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback